The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 21.25
Bid: 20.50
Ask: 22.00
Change: 0.15 (0.71%)
Spread: 1.50 (7.317%)
Open: 21.50
High: 22.00
Low: 21.25
Prev. Close: 21.10
IOF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Management changes

8 Mar 2010 07:00

RNS Number : 2049I
Iofina PLC
08 March 2010
 



 

8 March 2010

Iofina plc

 ("Iofina" or "the Company" or "the Group")

 

MANAGEMENT CHANGE

 

 

The Board of Iofina announces that following an organisation review in the light of the broadening scope of the Company's business Lance Baller, currently Finance Director of the Group, has been appointed as CEO of the Group in place of David Schneider, with immediate effect. It is expected that a new appointment to the role of Finance Director will be made shortly.

 Also, effective immediately, Dr Tom Becker has been appointed as President of Iofina Chemical Inc.

Dr. Becker was the former vice president of Research and Development at H&S/Iofina Chemical. Iofina bought H&S Chemical in July 2009 for complete vertical integration into the iodine chemical derivatives market. Dr. Becker has conducted extensive research in both inorganic and organic halogen based chemistry. Dr. Becker has written a magnitude of published technical papers in his career. Prior to H&S Dr. Becker worked as an Oak Ridge Scholar on behalf of the US EPA and worked for various other chemical manufacturing companies. Dr. Becker earned a BS in Chemistry from Indiana University, and a PhD in Chemistry from the University of Cincinnati. He has extensive experience in scale-up of chemical processes from laboratory to pilot to full scale production and is the inventor on several chemical patents/patent applications.

Dr. Chris Fay CBE, Non Executive Chairman commented:

"We are continually looking to strengthen Iofina's management team and Board as evidenced by a number of personnel announcements. As the Company's focus now transitions from one of exploration and technology development towards production, contract negotiations and cash generation, the Board has concluded that Lance is best placed to lead the Company through this next phase of growth to drive shareholder value creation."

For further information, please contact:

Chris Fay, Non-Exec Chairman

Iofina plc

Tel: +44(0)20 3006 3135

 

Nominated Adviser:

James Harris/Angela Peace

Strand Hanson Limited

Tel: +44(0)20 7409 3494

 

Broker:

Rory Scott

Mirabaud Securities Limited

Tel: +44(0)20 7878 3360

 

Media Contact:

Klara Kaczmarek

Pelham Bell Pottinger

Tel: +44 (0)20 7337 1524

About Iofina

Iofina is involved in the exploration and production of both iodine and natural gas with complete vertical integration into the specialty chemical iodine derivatives business. It also provides third party brine stream operators with a turnkey solution to extract iodine. The presence of both iodine and natural gas has been discovered on acreages which the Company holds through its wholly owned subsidiary Iofina Natural Gas, Inc. The presence of both iodine and natural gas allows the Group to generate dual revenue streams over a single cost structure.

Iofina is traded on the London Stock Exchange's AIM Market under the ticker: IOF

www.Iofina.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUGUMCWUPUPUM
Date   Source Headline
22nd Sep 20177:00 amRNSInterim Results
12th Sep 20177:00 amRNSConstruction of IO#7 to Expand Iodine Production
14th Jul 20177:00 amRNSCorporate and Production Update
14th Jun 201712:15 pmRNSResult of AGM
13th Jun 201712:07 pmRNSSecond Price Monitoring Extn
13th Jun 201712:02 pmRNSPrice Monitoring Extension
8th Jun 201712:07 pmRNSSecond Price Monitoring Extn
8th Jun 201712:02 pmRNSPrice Monitoring Extension
7th Jun 201712:07 pmRNSSecond Price Monitoring Extn
7th Jun 201712:02 pmRNSPrice Monitoring Extension
6th Jun 201712:07 pmRNSSecond Price Monitoring Extn
6th Jun 201712:02 pmRNSPrice Monitoring Extension
24th May 20174:40 pmRNSSecond Price Monitoring Extn
24th May 20174:35 pmRNSPrice Monitoring Extension
24th May 201712:07 pmRNSSecond Price Monitoring Extn
24th May 201712:02 pmRNSPrice Monitoring Extension
19th May 20177:00 amRNSFinal Results and Notice of AGM
3rd May 20174:41 pmRNSSecond Price Monitoring Extn
3rd May 20174:35 pmRNSPrice Monitoring Extension
25th Apr 20174:40 pmRNSSecond Price Monitoring Extn
25th Apr 20174:35 pmRNSPrice Monitoring Extension
11th Apr 20177:00 amRNSTrading Update
3rd Apr 20177:00 amRNSProduction update
14th Feb 20174:35 pmRNSPrice Monitoring Extension
13th Jan 20177:00 amRNSCorporate Update
13th Dec 20164:35 pmRNSPrice Monitoring Extension
12th Dec 20167:00 amRNSCorporate update
2nd Dec 20167:00 amRNSChange of Registered Office
4th Nov 20167:00 amRNSDirectorate Change
13th Oct 20167:00 amRNSTrading Update
30th Sep 20167:00 amRNSCompletion of Debt Restructure
30th Sep 20167:00 amRNSInterim Results
12th Sep 20164:35 pmRNSPrice Monitoring Extension
17th Aug 20164:40 pmRNSSecond Price Monitoring Extn
17th Aug 20164:35 pmRNSPrice Monitoring Extension
11th Aug 20161:33 pmRNSWater Depot Permit Update
25th Jul 20164:40 pmRNSSecond Price Monitoring Extn
25th Jul 20164:35 pmRNSPrice Monitoring Extension
11th Jul 20167:00 amRNSCorporate and Production Update
7th Jun 201611:37 amRNSResult of AGM
7th Jun 20167:00 amRNSRestructure of Debt
9th May 20167:00 amRNSFinal Results and Notice of AGM
11th Apr 20167:00 amRNSMarket update
15th Feb 20167:00 amRNSDirectorate Change
18th Jan 20167:00 amRNSCorporate Update
14th Dec 20157:00 amRNSTrading Update
23rd Nov 20157:00 amRNSBrine Supply Update
28th Oct 20157:00 amRNSAppointment of CFO
15th Oct 20159:00 amRNSIofina becomes founding member of the WIA
9th Oct 20157:00 amRNSProduction and Corporate Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.